Literature DB >> 31743460

Metabolomics Signature for Non-Responders to Total Joint Replacement Surgery in Primary Osteoarthritis Patients: The Newfoundland Osteoarthritis Study.

Christie A Costello1, Ting Hu2, Ming Liu1, Weidong Zhang1,3, Andrew Furey4, Zhaozhi Fan5, Proton Rahman6, Edward W Randell7, Guangju Zhai1.   

Abstract

Although total joint replacement (TJR) surgery is considered as the most effective treatment for advanced osteoarthritis (OA) patients, up to one-third of patients reported unfavorable long-term post-operative pain outcomes. We aimed to identify metabolic biomarkers to predict non-responders to TJR using a metabolomics approach. TJR patients were recruited and followed-up at least 1-year post-surgery; TJR outcomes were assessed by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and function subscales. Targeted metabolomic profiling was performed on plasma samples collected pre-surgery and pairwise metabolite ratios, as proxies for enzymatic reactions, were calculated. Association tests were performed between each metabolite ratio and non-responders. The metabolome-wide significance was defined as p < 2 × 10-5 . A total of 461 TJR patients due to primary OA were included in the analysis. Fifteen percent of patients were classified as pain non-responders; 16% were classified as function non-responders. Lower baseline WOMAC pain and function scores were significantly associated with pain and function non-responders, respectively (both p < 0.03). Two metabolite ratios were significantly associated with pain non-responders; acetylcarnitine (C2) to phosphatidylcholine acyl-alkyl C40:1 (PC ae C40:1) was five times higher in pain non-responders whereas phosphatidylcholine diacyl C36:4 (PC aa C36:4) to isoleucine was twenty one times lower in pain non-responders than responders (all p ≤ 1.93 × 10-5 ). One metabolite ratio, glutamine to isoleucine, was significantly lower in function non-responders than responders (eight times lower; p = 1.08 × 10-5 ). Three metabolite ratios (C2 to PC ae C40:1, PC aa C36:4, and glutamine to isoleucine) related to inflammation and muscle breakdown could be considered as novel plasma markers for predicting non-responders to TJR and warrant further investigation.
© 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 38:793-802, 2020. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarkers; metabolomics; osteoarthritis; total joint replacement

Year:  2019        PMID: 31743460     DOI: 10.1002/jor.24529

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  6 in total

1.  The Metabolomics of Chronic Pain Conditions: A Systematic Review.

Authors:  Edwin N Aroke; Keesha L Powell-Roach
Journal:  Biol Res Nurs       Date:  2020-07-15       Impact factor: 2.522

2.  Glutathione, polyamine, and lysophosphatidylcholine synthesis pathways are associated with circulating pro-inflammatory cytokines.

Authors:  Ming Liu; Hongwei Zhang; Zikun Xie; Yiheng Huang; Guang Sun; Dake Qi; Andrew Furey; Edward W Randell; Proton Rahman; Guangju Zhai
Journal:  Metabolomics       Date:  2022-09-30       Impact factor: 4.747

3.  Restricting Branched-Chain Amino Acids within a High-Fat Diet Prevents Obesity.

Authors:  Ming Liu; Yiheng Huang; Hongwei Zhang; Dawn Aitken; Michael C Nevitt; Jason S Rockel; Jean-Pierre Pelletier; Cora E Lewis; James Torner; Yoga Raja Rampersaud; Anthony V Perruccio; Nizar N Mahomed; Andrew Furey; Edward W Randell; Proton Rahman; Guang Sun; Johanne Martel-Pelletier; Mohit Kapoor; Graeme Jones; David Felson; Dake Qi; Guangju Zhai
Journal:  Metabolites       Date:  2022-04-07

4.  Differential correlation network analysis identified novel metabolomics signatures for non-responders to total joint replacement in primary osteoarthritis patients.

Authors:  Christie A Costello; Ting Hu; Ming Liu; Weidong Zhang; Andrew Furey; Zhaozhi Fan; Proton Rahman; Edward W Randell; Guangju Zhai
Journal:  Metabolomics       Date:  2020-04-25       Impact factor: 4.290

5.  Macrophage migration inhibitory factor may play a protective role in osteoarthritis.

Authors:  Ming Liu; Zikun Xie; Guang Sun; Liujun Chen; Dake Qi; Hongwei Zhang; Jieying Xiong; Andrew Furey; Proton Rahman; Guanghua Lei; Guangju Zhai
Journal:  Arthritis Res Ther       Date:  2021-02-20       Impact factor: 5.156

6.  Identification of the key gene and pathways associated with osteoarthritis via single-cell RNA sequencing on synovial fibroblasts.

Authors:  Zhen Wu; Lu Shou; Jian Wang; Xinwei Xu
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.